Article ID Journal Published Year Pages File Type
8525971 Biomedicine & Pharmacotherapy 2018 7 Pages PDF
Abstract
There was no apparent difference on improving vision between SDMLP monotherapy and CLP monotherapy. The most effective treatment in the network was ranibizumab therapy combined with CLP followed by SDMLP monotherapy, Bevacizumab therapy combined with CLP, and CLP monotherapy in rank order.
Related Topics
Health Sciences Medicine and Dentistry Oncology
Authors
, , , ,